BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27823971)

  • 1. Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients.
    Kim TH; Yun TJ; Park CK; Kim TM; Kim JH; Sohn CH; Won JK; Park SH; Kim IH; Choi SH
    Oncotarget; 2017 Mar; 8(12):20340-20353. PubMed ID: 27823971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and
    Qiao Z; Zhao X; Wang K; Zhang Y; Fan D; Yu T; Shen H; Chen Q; Ai L
    AJNR Am J Neuroradiol; 2019 Feb; 40(2):253-259. PubMed ID: 30655259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute CBV for the differentiation of recurrence and radionecrosis of brain metastases after gamma knife radiotherapy: a comparison with relative CBV.
    Wang B; Zhao B; Zhang Y; Ge M; Zhao P; Na Sun ; Li C; Pang Q; Xu S; Liu Y
    Clin Radiol; 2018 Aug; 73(8):758.e1-758.e7. PubMed ID: 29764622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis?
    Vidiri A; Guerrisi A; Pinzi V; Fabi A; Mirri MA; Pompili A; Caporale N; Pace A; Crecco M; Marzi S
    Eur J Radiol; 2012 Jun; 81(6):1246-52. PubMed ID: 21458183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postcontrast T1 Mapping for Differential Diagnosis of Recurrence and Radionecrosis after Gamma Knife Radiosurgery for Brain Metastasis.
    Wang B; Zhang Y; Zhao B; Zhao P; Ge M; Gao M; Ding F; Xu S; Liu Y
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1025-1031. PubMed ID: 29724761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of Recurrent/Residual Glioma From Radiation Necrosis Using Semi Quantitative 99mTc MDM (Bis-Methionine-DTPA) Brain SPECT/CT and Dynamic Susceptibility Contrast-Enhanced MR Perfusion: A Comparative Study.
    Rani N; Singh B; Kumar N; Singh P; Hazari PP; Singh H; Kumar G; Radotra B; Kumar M; Bhattacharya A; Sharma R; Kohli A; Chhabra R; Gupta SK; Mishra AK
    Clin Nucl Med; 2018 Mar; 43(3):e74-e81. PubMed ID: 29356734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility-weighted imaging cannot distinguish radionecrosis from recurrence in brain metastases after radiotherapy: a comparison with high-grade gliomas.
    Qin J; Yu Z; Yao Y; Liang Y; Tang Y; Wang B
    Clin Radiol; 2022 Aug; 77(8):e585-e591. PubMed ID: 35676103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
    Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
    Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of
    Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
    Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
    Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
    Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning in the detection of high-grade glioma recurrence using multiple MRI sequences: A pilot study.
    Bacchi S; Zerner T; Dongas J; Asahina AT; Abou-Hamden A; Otto S; Oakden-Rayner L; Patel S
    J Clin Neurosci; 2019 Dec; 70():11-13. PubMed ID: 31648967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging.
    Wang YL; Chen S; Xiao HF; Li Y; Wang Y; Liu G; Lou X; Ma L
    Radiother Oncol; 2018 Oct; 129(1):68-74. PubMed ID: 29398151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
    Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
    Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading.
    Kim H; Choi SH; Kim JH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH
    PLoS One; 2013; 8(5):e63462. PubMed ID: 23704910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.